Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Smoking Prevalence at a University Hospital (TABAC-HCL)

8 de junio de 2018 actualizado por: Hospices Civils de Lyon

Study of Smoking Prevalence at the "Hospices Civils de Lyon"

  • Tobacco is the leading risk factor for avoidable mortality in France and around the world. It is also the second cause of life with disability in the world and the leading preventable risk factor for cancer in France and worldwide.
  • The "Health Barometer" studies carried out for 25 years in France by Santé-Publique France assessed prevalence of smoking in the lay population. These studies showed that smoking prevalence has stabilized among 15-75 year olds (34.1% of current smokers) with a slight decrease in regular smoking (from 29.1% in 2010 to 28.2% in 2014).
  • Data on the prevalence of smoking among hospital staff are contradictory. Some studies find a higher prevalence of active smoking than the general population; others have a lower prevalence. However, it appears that an active prevention policy with hospital staff can significantly and rapidly reduce the prevalence of active smoking.
  • The prevalence of active smoking in patients is logically higher than in the general population (at comparable age).
  • The data on the prevalence of smoking among medical students are also contradictory. Yet, this population is a special interest group given their future investment in patient care.
  • Cannabis use also appears to be an independent risk factor for respiratory diseases and broncho-pulmonary cancers. Cannabis use among health students is not uncommon (11.5% of students). To our knowledge, the measurement of the prevalence of Cannabis use in an all-patient population of a hospital-university facility has never been achieved.
  • According to the health barometer 2014, about a quarter of 15-75 year olds have already tried electronic cigarettes and 6% are regular current users. Although the toxicity of the electronic cigarette and its interest in weaning remain controversial, its use to patients, staff or patients has been reported very little.

The aim of this study is to assess the impact of collective and individual tobacco control measures by measuring the prevalence of smoking on a given day at the "Hospices Civils de Lyon", among patients, staff and students present on a given day.

Descripción general del estudio

Tipo de estudio

De observación

Inscripción (Actual)

11276

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Pierre-Bénite, Francia, 69495
        • Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique - Hôpital Lyon-Sud

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Three populations are identified:

  • Patients group: All persons admitted to the Hospices Cvils de Lyon on the day of the investigation, whatever the reason.
  • Hospital staff group: All members of the staff of the Hospices Civils de Lyon, present at their place of work on the day of the inquiry, whatever their status.
  • Students group: All students of the faculties of medicine of Université Lyon I and of the Hospices Civils de Lyon training institutes present in the university or training institute on the day of the survey, whatever their status.

Descripción

Inclusion Criteria:

- Patients group: Any person, over 18 years of age, hospitalized in one of the establishments of the Hospices Civils de Lyon, whatever the reason and the duration.

- Hospital staff group: Anyone, whatever age and trade, paid directly by the Hospices Civils de Lyon on the day of the survey, regardless of the duration of the employment contract, and present on one of the sites of the Hospices Civils de Lyon the day of the investigation.

- Students group: Everyone who is regularly enrolled in one of the schools or institutes of the Hospices Civils de Lyon or in one of the two faculties of medicine of the Université Lyon I, in any initial training and present on one of the sites of the faculties the day of the investigation

Exclusion Criteria:

  • Patients group:

    • Refusal to participate
    • Refusal of parents or legal representative for minors or adults of full age.
    • Child under the age of 18 at the time of the survey.
    • Individual who do not speak, understand or read the French language.
    • Non-hospitalized individuals (including external consultants).
    • Patient whose clinical status is not compatible with the administration of the questionnaire (eg, disorders of consciousness, severe cognitive impairment, severe speech disturbances, extreme asthenia) as judged by the service health framework and / or the medical team of the service.
    • Individual currently incarcerated.
  • Hospital staff group:

    • Refusal to participate.
    • Temporary staff (not paid directly by the Hospices Civils de Lyon on the day of the survey).
    • Students present on the day of the survey, and in particular: hospital students, nursing students and nursing assistants.
  • Students group:

    • Refusal to participate
    • Professional present in the school / institute / faculty as part of continuing education.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Patients group
All patients (over 18y) admitted to the Hospices Civils de Lyon the day of the study, whatever the reason, able to fullfill the questionnaire by themselves.
One-page questionnaire with 17 questions about tobacco habits
Hospital staff group
Anyone, whatever age and trade, paid directly by the Hospices Civils de Lyon on the day of the survey, regardless of the duration of the employment contract, and present on one of the sites of the Hospices Civils de Lyon the day of the investigation.
One-page questionnaire with 15 questions about tobacco habits
Students group
Everyone who is regularly enrolled in one of the schools or institutes of the Hospices Civils de Lyon or in one of the two faculties of medicine of the Université Lyon I, in any initial training and present on one of the sites of the faculties the day of the investigation
One-page questionnaire with 17 questions about tobacco habits

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Measure the prevalence of smoking one day given to the Hospices Civils de Lyon, in patients, the members of the staff and students present one day
Periodo de tiempo: One day

The aim of this study is to determine the proportion of active smoker / smoker weaned / non-smoker in each group (patients / hospital staff / students).

Data are collected by a questionnaire.

One day

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

23 de noviembre de 2017

Finalización primaria (Actual)

23 de noviembre de 2017

Finalización del estudio (Actual)

23 de noviembre de 2017

Fechas de registro del estudio

Enviado por primera vez

28 de agosto de 2017

Primero enviado que cumplió con los criterios de control de calidad

29 de agosto de 2017

Publicado por primera vez (Actual)

31 de agosto de 2017

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

11 de junio de 2018

Última actualización enviada que cumplió con los criterios de control de calidad

8 de junio de 2018

Última verificación

1 de agosto de 2017

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 69HCL17_0481

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

3
Suscribir